Titan Pharmaplus Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.70 Cr
About Titan Pharmaplus
Titan Pharmaplus Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 March 2022 (Two years and ten months 26 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹21.70 Cr.
Piyush Shah and Deepak Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51397MH2022PTC378007
- Company No.
378007
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Titan Pharmaplus?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Shah  | Director | 07-Mar-2022 | Current |
| Deepak Shah | Director | 07-Mar-2022 | Current |
Financial Performance of Titan Pharmaplus.
Enhance accessibility to Titan Pharmaplus's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Titan Pharmaplus?
Unlock access to Titan Pharmaplus's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Titan Laboratories Private LimitedPiyush Shah and Deepak Shah are mutual person
Titan Pharma (India ) Private LimitedPiyush Shah and Deepak Shah are mutual person
Charges (Loans)
₹21.70 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 21.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2024 | Others | ₹3.00 Cr | Open |
| 10 Jan 2024 | Others | ₹17.00 Cr | Open |
| 10 Jan 2024 | Others | ₹1.70 Cr | Open |
How Many Employees Work at Titan Pharmaplus?
Unlock and access historical data on people associated with Titan Pharmaplus, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Titan Pharmaplus, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Titan Pharmaplus's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
